Skip to main content
. 2024 Jan 18;73(1):14. doi: 10.1007/s00262-023-03626-w

Table 2.

Response to immunotherapy based on the prediction model

Survival prediction Low High χ2 P
For training cohort (n = 130) n = 101 n = 29
Best overall response-no. (%) 12.134 0.002
Partial response (PR) 33 (32.7) 5 (17.2)
Stable disease (SD) 57 (56.4) 13 (44.8)
Progressive disease (PD) 11 (10.9) 11 (37.9)
For validation cohort (n = 63) n = 46 n = 17
Best overall response-no. (%) 7.603 0.022
Partial response (PR) 15 (32.6) 2 (11.8)
Stable disease (SD) 27 (58.7) 9 (52.9)
Progressive disease (PD) 4 (8.7) 6 (35.3)